What is Medqor?
Medqor operates at the intersection of medical technology and business intelligence through its flagship platform, Chronicle. By providing real-time, data-centric insights into the U.S. healthcare landscape, the company facilitates the accelerated market entry of advanced pharmaceuticals and medical devices. Its core value proposition lies in equipping healthcare professionals with actionable data, thereby optimizing clinical procedures and driving superior patient outcomes. As a leader in healthcare analytics, Medqor bridges the gap between raw market data and clinical application, positioning itself as an essential utility for stakeholders navigating the evolving medical regulatory and commercial environment.
How much funding has Medqor raised?
Medqor has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Medqor
PPP
Public-Private Partnership
What's next for Medqor?
Following this substantial capital infusion, Medqor is well-positioned to expand its market footprint and enhance the analytical capabilities of the Chronicle platform. The strategic focus will likely shift toward deepening its data integration layers and broadening its reach among healthcare providers and pharmaceutical manufacturers. By leveraging this late-stage backing, the company aims to solidify its dominance in the healthcare intelligence sector, potentially exploring new vertical integrations or advanced predictive modeling features that further streamline the adoption of life-saving medical technologies. The firm remains committed to its mission of data-driven clinical optimization, ensuring that its technological infrastructure remains at the forefront of the industry.
See full Medqor company page
